Power Law company profile

Kythera Biopharmaceuticals

Biotech & Life Sciences · Calabasas, United States · Founded 2005 · IPO 2012 Unicorn

Focuses on the discovery, development, and commercialization of prescription products for the aesthetic medicine market in the United States and internationally

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

12 investors on Kythera Biopharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage

Versant Ventures

Series B+ 11 investors entered at this stage

Wilson Sonsini

UCLA VC Fund

Invus

Foley Ventures

Apothecary Capital

Altitude Life Science Ventures

BB&T

ARCH Venture Partners

Prospect Venture Partners

Latham & Watkins

WS Investments

Global footprint

Where Kythera Biopharmaceuticals has talent and traffic

Workforce by country

🇺🇸 United States · Calabasas HQ

Book a demo for the full country breakdown

Patent intelligence

$13M patent portfolio · 17 active families

Estimated portfolio value

$13M

39.4× smaller than top peer ChemoCentryx ($524M)

17 active patent families

Where Kythera Biopharmaceuticals innovates Deoxycholic acidChemistryOrganic chemistryDesoxycholic acidMedicinal chemistry

Where Kythera Biopharmaceuticals concentrates vs peers

Each axis is a top-10 topic across Kythera Biopharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Kythera Biopharmaceuticals

An AI-synthesized read of the highest-engagement posts about Kythera Biopharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Kythera Biopharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles